Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anna Kajaste-Rudnitski

Showing results (11-20 of 43) with videos related to

Pageof 5
Sort By:
La Medicina Del Lavoro|July 31, 2012
Assessment of efficacy and safety of pandemic A/H1N1/2009 influenza vaccine in a group of health care workersP Mascagni, Elisa Vicenzi, Anna Kajaste-Rudnitski, et al.
The Journal of Gene Medicine|March 15, 2008
A dimerizable cationic lipid with potential for gene deliveryGabriele Candiani, Daniele Pezzoli, Mariasara Cabras, et al.
Virology|January 27, 2010
Viral determinants in the NS3 helicase and 2K peptide that promote West Nile virus resistance to antiviral action of 2',5'-oligoadenylate synthetase 1bEva Mertens, Anna Kajaste-Rudnitski, Shessy Torres, et al.
Blood|January 12, 2012
HIV-1 envelope-dependent restriction of CXCR4-using viruses in child but not adult untransformed CD4+ T-lymphocyte linesSamanta A Mariani, Immacolata Brigida, Anna Kajaste-Rudnitski, et al.
Retrovirology|December 20, 2015
HIV-1 transcriptional silencing caused by TRIM22 inhibition of Sp1 binding to the viral promoterFilippo Turrini, Sara Marelli, Anna Kajaste-Rudnitski, et al.
AIDS (London, England)|December 15, 2010
Induction of protective antibody response by MF59-adjuvanted 2009 pandemic A/H1N1v influenza vaccine in HIV-1-infected individualsAnna Kajaste-Rudnitski, Laura Galli, Silvia Nozza, et al.
Stem Cell Reports|March 24, 2017
Efficient Ex Vivo Engineering and Expansion of Highly Purified Human Hematopoietic Stem and Progenitor Cell Populations for Gene TherapyErika Zonari, Giacomo Desantis, Carolina Petrillo, et al.
EMBO Molecular Medicine|July 2, 2017
Lentiviral vectors escape innate sensing but trigger p53 in human hematopoietic stem and progenitor cellsFrancesco Piras, Michela Riba, Carolina Petrillo, et al.
Antimicrobial Agents and Chemotherapy|June 25, 2008
Inhibition of herpes simplex virus types 1 and 2 in vitro infection by sulfated derivatives of Escherichia coli K5 polysaccharideDebora Pinna, Pasqua Oreste, Tiziana Coradin, et al.
AIDS (London, England)|August 8, 2013
Identification of TRIM22 single nucleotide polymorphisms associated with loss of inhibition of HIV-1 transcription and advanced HIV-1 diseaseSilvia Ghezzi, Laura Galli, Anna Kajaste-Rudnitski, et al.
Pageof 5

Showing results (11-20 of 43) with videos related to

Sort By:
Pageof 5
La Medicina Del Lavoro|July 31, 2012
Assessment of efficacy and safety of pandemic A/H1N1/2009 influenza vaccine in a group of health care workersP Mascagni, Elisa Vicenzi, Anna Kajaste-Rudnitski, et al.
The Journal of Gene Medicine|March 15, 2008
A dimerizable cationic lipid with potential for gene deliveryGabriele Candiani, Daniele Pezzoli, Mariasara Cabras, et al.
Virology|January 27, 2010
Viral determinants in the NS3 helicase and 2K peptide that promote West Nile virus resistance to antiviral action of 2',5'-oligoadenylate synthetase 1bEva Mertens, Anna Kajaste-Rudnitski, Shessy Torres, et al.
Blood|January 12, 2012
HIV-1 envelope-dependent restriction of CXCR4-using viruses in child but not adult untransformed CD4+ T-lymphocyte linesSamanta A Mariani, Immacolata Brigida, Anna Kajaste-Rudnitski, et al.
Retrovirology|December 20, 2015
HIV-1 transcriptional silencing caused by TRIM22 inhibition of Sp1 binding to the viral promoterFilippo Turrini, Sara Marelli, Anna Kajaste-Rudnitski, et al.
AIDS (London, England)|December 15, 2010
Induction of protective antibody response by MF59-adjuvanted 2009 pandemic A/H1N1v influenza vaccine in HIV-1-infected individualsAnna Kajaste-Rudnitski, Laura Galli, Silvia Nozza, et al.
Stem Cell Reports|March 24, 2017
Efficient Ex Vivo Engineering and Expansion of Highly Purified Human Hematopoietic Stem and Progenitor Cell Populations for Gene TherapyErika Zonari, Giacomo Desantis, Carolina Petrillo, et al.
EMBO Molecular Medicine|July 2, 2017
Lentiviral vectors escape innate sensing but trigger p53 in human hematopoietic stem and progenitor cellsFrancesco Piras, Michela Riba, Carolina Petrillo, et al.
Antimicrobial Agents and Chemotherapy|June 25, 2008
Inhibition of herpes simplex virus types 1 and 2 in vitro infection by sulfated derivatives of Escherichia coli K5 polysaccharideDebora Pinna, Pasqua Oreste, Tiziana Coradin, et al.
AIDS (London, England)|August 8, 2013
Identification of TRIM22 single nucleotide polymorphisms associated with loss of inhibition of HIV-1 transcription and advanced HIV-1 diseaseSilvia Ghezzi, Laura Galli, Anna Kajaste-Rudnitski, et al.
Pageof 5